Baxter International Inc. Product Pipeline AnalysisSummaryThis report is an insightful source for data, analysis and strategic insights into a Scope's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.Scope' Details of development stage by sector and equipment type.' Pipeline products grouped by therapy area, development stage and trial phase.' Detailed information on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results.' Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.' Product updates covering estimated approval dates and estimated launch dates.' Descriptions of novel technologies relating to pipeline products of the company.' Patents and patent applications covered for the product.' News updates on key events relating to the product and its development.Reasons to buy' A single source to fulfill competitor information relating to products in development.' Identify pipeline products that are potential competitor to your product lines.' Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.' Access clinical trial information to map trial results and plan targeted marketing activities.' Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.' Identification of potential investment opportunities.' Build up knowledge base for potential distribution and marketing partners.' Helps avoid patent infringement.' Timelines from concept to market lets you keep track of market potential build for a new product.' Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Baxter International Inc. Product Pipeline Analysis
Published on January 2009
Report Summary
Baxter International Inc. Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope's pipeline and investigational products. The
report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary
end-points and trial results for products in development.
Scope
' Details of development stage by sector and equipment type.
' Pipeline products grouped by therapy area, development stage and trial phase.
' Detailed information on clinical trials covering trial phase, description, investigator information, primary and secondary end-points
and trial results.
' Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
' Product updates covering estimated approval dates and estimated launch dates.
' Descriptions of novel technologies relating to pipeline products of the company.
' Patents and patent applications covered for the product.
' News updates on key events relating to the product and its development.
Reasons to buy
' A single source to fulfill competitor information relating to products in development.
' Identify pipeline products that are potential competitor to your product lines.
' Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
' Access clinical trial information to map trial results and plan targeted marketing activities.
' Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product
pipelines.
' Identification of potential investment opportunities.
' Build up knowledge base for potential distribution and marketing partners.
' Helps avoid patent infringement.
' Timelines from concept to market lets you keep track of market potential build for a new product.
' Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
Table of Content
1 Table of Contents 2
1.1 List of Tables 4
Baxter International Inc. Product Pipeline Analysis Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
1.2 List of Figures 5
2 Company Snapshot 6
2.1 Key Information 6
2.2 Company Overview 6
3 Baxter International Inc. Pipeline Products 7
3.1 Baxter International Inc. Product Pipeline Analysis 7
3.1.1 Baxter International Inc. Pipeline Products By Equipment Type 7
3.1.2 Baxter International Inc. Pipeline Products By Development Stage 7
3.1.3 Baxter International Inc. Pipeline Products By Therapy Area 7
3.1.4 Baxter International Inc. Pipeline Products By News Summary 7
3.2 Next-Generation Home Hemodialysis Machine 8
3.2.1 Product Status 8
3.2.2 Product Description 8
3.2.3 Product Milestone 8
3.2.4 Product Institution Details 9
3.3 APD Cycler 9
3.3.1 Product Status 9
3.3.2 Product Description 9
3.4 ProMaxx Technology 9
3.4.1 Product Status 9
3.4.2 Product Description 10
3.4.3 Product Milestone 10
4 Recent Developments 11
4.1 Product News 11
4.1.1 Sep 29, 2008: Baxter's Antimicrobial IV Technology Shown To Kill Six Common Pathogens, Including MRSA And VRE 11
4.1.2 Apr 09, 2008: Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 11
4.1.3 Mar 20, 2008: Baxter Announces FDA Approval Of ARTISS Slow-Setting Fibrin Sealant In Treatment Of Burn Patients 12
4.1.4 Dec 17, 2007: Baxter Announces FDA Approval Of GELFOAM Plus Hemostasis Kit 12
4.1.5 Dec 13, 2007: MediGuide Received A CE Mark Certificate For Its Medical Positioning System (gMPS) And gMPS Enable
Guided Measurement Catheter (GMC) 12
4.1.6 Nov 09, 2007: Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular
Technology 13
4.1.7 Aug 06, 2007: Baxter Announces Collaboration For Development Of Next-Generation Home Hemodialysis Machine 14
4.1.8 Feb 27, 2007: Baxter Receives 510(K) Clearance From FDA For COLLEAGUE Infusion Pumps 14
4.1.9 Feb 06, 2007: Baxter Receives Clearance From US FDA For Ipump Pain Management System 510(k) 14
4.2 Product Approvals 15
4.2.1 Mar 20, 2008: Baxter Announces FDA Approval Of ARTISS Slow-Setting Fibrin Sealant In Treatment Of Burn Patients 15
4.2.2 Dec 17, 2007: Baxter Announces FDA Approval Of GELFOAM Plus Hemostasis Kit 15
4.2.3 Dec 13, 2007: MediGuide Received A CE Mark Certificate For Its Medical Positioning System (gMPS) And gMPS Enable
Guided Measurement Catheter (GMC) 16
4.2.4 Nov 09, 2007: Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular
Technology 16
4.2.5 Feb 27, 2007: Baxter Receives 510(K) Clearance From FDA For COLLEAGUE Infusion Pumps 17
4.2.6 Feb 06, 2007: Baxter Receives Clearance From US FDA For Ipump Pain Management System 510(k) 17
5 Appendix 19
5.1 Methodology 19
5.1.1 Coverage 19
5.1.2 Secondary Research 20
5.1.3 Primary Research 20
5.1.4 Expert Panel Validation 21
Baxter International Inc. Product Pipeline Analysis Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
5.2 Contact Us 21
5.3 About Global Markets Direct 21
5.4 Disclaimer 21
1.2 List of Figures
Figure 1: Global Markets Direct Methodology 19
Baxter International Inc. Product Pipeline Analysis Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Baxter International Inc. Product Pipeline Analysis
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 750.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Baxter International Inc. Product Pipeline Analysis Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Baxter International Inc. Product Pipeline Analysis Page 5/5